has role has attribute value has attribute antibacterial drug organic molecular entity topoisomerase IV inhibitor DNA synthesis inhibitor levofloxacin (-)-Ofloxacin (3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (S)-Ofloxacin An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase CAS:100986-85-4 CHEBI:63598 DrugBank:DB01137 Drug_Central:1569 L-Ofloxacin LINCS:LSM-5270 Ofloxacin S-(-)-form PMID:21075586 PMID:21965436 PMID:21974858 PMID:22088660 PMID:22221614 Reaxys:5385660 levofloxacin levofloxacine levofloxacino levofloxacinum drug liver toxicity Most-DILI-Concern